News in Numbers

85% or 110 million infants were immunised worldwide in 2025, with the figure representative of almost one million more infants than 2024, according to new data from the World Health Organization.

Women’s health companies secured a record $1.55bn in funding in 2025, according to new research by W Group.

Moderna has agreed a contract with the European Commission (EC) that will see tens of millions of respiratory syncytial virus (RSV) vaccine doses accessible to member countries in time for the 2026-2027 winter season.

The recent agreed UK-US pharmaceuticals deal could cost the NHS around £45bn ($60bn) within a decade and divert resources away from essential services, an analysis published in the British Medical Journal (BMJ) has suggested.

Anthropic has released a new pharmaceutical R&D tool, Claude Science, that comes with over 60 functions catering to areas like genomics, structural biology, proteomics and cheminformatics.